pharmaceutical products, namely, prophylactic drugs preventing calcium absorption by the human body, therapeutic multivitamin combinations, orally administered dietary supplements of calcium salt, orally administered dietary supplements of calcium salt with vitamin D, laxatives, analgesic preparations for internal use or topical application, antacid tablets for gastric hyperacidity, antispasmodic treatments, hematinic tablets of ferrous gluconate, therapeutic flouride, folic acid tablets, preparations for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance, orally administered sodium salt tablets, high carbohydrate protein dietary food supplements, preparations for the treatment of secondary anemia, pharmaceutical preparations in chewable tablet dosage form, namely, antispasmodic, anticholinergics, antacids, antihistamines, antibiotics, antiasmatics and antinauseas, for dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stones, for surgical lubricating jelly, vitamin and mineral preparations in liquid tablet and capsule form, slow-release salt tablets, prophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stones, orally administered potassium phosphate preparations utilized for treatment of kidney stones, pharmacuetical products prepared as an appetite depressant